Reduction in Heart Failure Hospitalizations Through Real-World HeartLogicTM Alert Response ― A Multicenter Study in Japan ―
Circulation Journal · 2026
DOI: 10.1253/circj.cj-26-0182 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Circulation Journal, 2026. Verfasst von Takafumi Oka und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, the University of Osaka Graduate School of Medicine. Hauptthemen laut MEDLINE: Heart Failure, Hospitalization, Defibrillators, Implantable. Die Arbeit nennt 34 Literaturangaben.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
BACKGROUND: Heart failure (HF) is a progressive disease characterized by an increasing incidence of hospitalization over time. HeartLogicTM(HL) is a multiparametric remote monitoring system designed to detect early signs of HF decompensation. Using a multicenter database, this real-world study evaluated whether responses to HL alerts could reduce HF-related hospitalization. METHODS AND RESULTS: We retrospectively analyzed 246 patients implanted with an HL-enabled implantable cardioverter-defibrillator or cardiac resynchronization therapy defibrillator across 8 Japanese centers. Patients were categorized as alert-responsive (AR; n=167) or non-responsive (NR; n=79). Alert responses included multidisciplinary review and telephone triage to determine the need for clinical visits. HF hospitalization rates during the alert-off (before activation) and the alert-on (after alert activation) periods were compared. During the alert-off period, 50 hospitalizations occurred over 648 person-years (77.1 per 1,000 person-years); during the alert-on, 91 hospitalizations occurred over 498 person-years (182.6 per 1,000 person-years). From the alert-off to the alert-on period, HF hospitalization increased 3.24-fold (95% confidence interval [CI] 1.63-6.41) in the NR group, but only 1.28-fold (95% CI 0.81-2.03) in the AR group. The relative increase in HF hospitalization was significantly attenuated in the AR group (adjusted relative ratio 0.40; 95% CI 0.18-0.89; P=0.025). CONCLUSIONS: Although HF-related hospitalizations progressively increase as the disease advances, real-world alert responses may reduce hospitalizations and healthcare costs in clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine, the University of Osaka Graduate School of Medicine.
- Department of Laboratory Medicine, the University of Osaka Graduate School of Medicine.
- Department of Cardiology, Tokyo Women's Medical University.
- Department of Cardiology, Kokura Memorial Hospital.
- Department of Cardiology, Division for Heart Rhythm Management, Tokyo Women's Medical University.
- Department of Cardiac Electrophysiology, Saitama Medical University International Medical Center.
Zitieren
APA
Oka, T., Takahara, M., Kataoka, S., Nagashima, M., Onuki, K., Yagishita, D., Ikeda, Y., Kanai, R., Terazaki, Y., Yoshiga, Y., Fukuda, M., Tsurugi, T., Fujiu, K., Hasumi, E., Nishii, N., Iguchi, H., & Sakata, Y. (2026). Reduction in Heart Failure Hospitalizations Through Real-World HeartLogicTM Alert Response ― A Multicenter Study in Japan ―. Circulation Journal. https://doi.org/10.1253/circj.cj-26-0182
Vancouver
Oka T, Takahara M, Kataoka S, Nagashima M, Onuki K, Yagishita D, et al. Reduction in Heart Failure Hospitalizations Through Real-World HeartLogicTM Alert Response ― A Multicenter Study in Japan ―. Circulation Journal. 2026. doi:10.1253/circj.cj-26-0182
BibTeX
@article{Oka2026,
author = {Oka, Takafumi and Takahara, Mitsuyoshi and Kataoka, Shohei and Nagashima, Michio and Onuki, Koumei and Yagishita, Daigo and Ikeda, Yoshifumi and Kanai, Risa and Terazaki, Yoshitaka and Yoshiga, Yasuhiro and Fukuda, Masakazu and Tsurugi, Takuo and Fujiu, Katsuhito and Hasumi, Eriko and Nishii, Nobuhiro and Iguchi, Hiroki and Sakata, Yasushi},
title = {Reduction in Heart Failure Hospitalizations Through Real-World HeartLogicTM Alert Response ― A Multicenter Study in Japan ―},
journal = {Circulation Journal},
year = {2026},
doi = {10.1253/circj.cj-26-0182}
}
EUVIMED